|
|
|
|
LEADER |
03132nam a2200505 4500 |
001 |
978-3-319-76478-8 |
003 |
DE-He213 |
005 |
20191025082058.0 |
007 |
cr nn 008mamaa |
008 |
180605s2018 gw | s |||| 0|eng d |
020 |
|
|
|a 9783319764788
|9 978-3-319-76478-8
|
024 |
7 |
|
|a 10.1007/978-3-319-76478-8
|2 doi
|
040 |
|
|
|d GrThAP
|
050 |
|
4 |
|a RB1-214
|
072 |
|
7 |
|a MMF
|2 bicssc
|
072 |
|
7 |
|a MED067000
|2 bisacsh
|
072 |
|
7 |
|a MKF
|2 thema
|
082 |
0 |
4 |
|a 616.07
|2 23
|
245 |
1 |
0 |
|a Serous Effusions
|h [electronic resource] :
|b Etiology, Diagnosis, Prognosis and Therapy /
|c edited by Ben Davidson, Pinar Firat, Claire W. Michael.
|
250 |
|
|
|a 2nd ed. 2018.
|
264 |
|
1 |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2018.
|
300 |
|
|
|a VII, 306 p. 279 illus., 269 illus. in color.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
505 |
0 |
|
|a Benign effusions -- Lung carcinoma -- Ovarian/primary peritoneal carcinoma -- Breast carcinoma -- Malignant mesothelioma -- Hematological hematologic and lymphoid neoplasia -- Cancer of other origin -- Lung carcinoma -- Ovarian/primary peritoneal carcinoma -- Breast carcinoma -- Malignant mesothelioma -- Cancer of other origin.
|
520 |
|
|
|a This revised and updated second edition contains multiple microscopic illustrations of all diagnostic entities and ancillary techniques, providing a comprehensive, authoritative guide to all aspects of serous effusions. It now includes the many new antibodies which have been tested since the previous edition, as well as a discussion on next-generation sequencing and molecularly targeted therapy. Section one covers diagnosis for benign and malignant effusions while section two discusses biology, therapy, and prognosis highlighting clinical approaches that may be of value. Serous Effusions provides an indispensable guide to all aspects of current practice for cytopathologists, cytotechnicians, pathologists, clinicians and researchers in training and practice.
|
650 |
|
0 |
|a Pathology.
|
650 |
|
0 |
|a Oncology .
|
650 |
|
0 |
|a Medical biochemistry.
|
650 |
1 |
4 |
|a Pathology.
|0 http://scigraph.springernature.com/things/product-market-codes/H4800X
|
650 |
2 |
4 |
|a Oncology.
|0 http://scigraph.springernature.com/things/product-market-codes/H33160
|
650 |
2 |
4 |
|a Medical Biochemistry.
|0 http://scigraph.springernature.com/things/product-market-codes/H35005
|
700 |
1 |
|
|a Davidson, Ben.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
700 |
1 |
|
|a Firat, Pinar.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
700 |
1 |
|
|a Michael, Claire W.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
776 |
0 |
8 |
|i Printed edition:
|z 9783319764771
|
776 |
0 |
8 |
|i Printed edition:
|z 9783319764795
|
776 |
0 |
8 |
|i Printed edition:
|z 9783030094980
|
856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-319-76478-8
|z Full Text via HEAL-Link
|
912 |
|
|
|a ZDB-2-SME
|
950 |
|
|
|a Medicine (Springer-11650)
|